|
KMID : 1144320150470030212
|
|
감염과 화학요법
2015 Volume.47 No. 3 p.212 ~ p.222
|
|
|
Antiviral Treatment Guidelines for Middle East Respiratory Syndrome
|
|
Chong Yong-Pil
Song Joon-Young
Seo Yu-Bin
Choi Jae-Phil
Shin Hyoung-Shik
Rapid Response Team
|
|
|
Abstract
|
|
|
|
Middle East respiratory syndrome (MERS) is an acute infectious disease of the respiratory system caused by the new betacoronavirus (MERS coronavirus, MERS-CoV), which shows high mortality rates. The typical symptoms of MERS are fever, cough, and shortness of breath, and it is often accompanied by pneumonia. The MERS-CoV was introduced to Republic of Korea in May 2015 by a patient returning from Saudi Arabia. The disease spread mostly through hospital infections, and by the time the epidemic ended in August, the total number of confirmed diagnoses was 186, among which 36 patients died. Reflecting the latest evidence for antiviral drugs in the treatment of MERS-CoV infection and the experiences of treating MERS patients in Republic of Korea, these guidelines focus on antiviral drugs to achieve effective treatment of MERS-CoV infections.
|
|
|
KEYWORD
|
|
|
Coronavirus, Antiviral, Treatment
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|